A Science and Technology Blog
Transfer of genes from genetically-modified Aedes aegypti mosquitoes to naturally-occurring ones were seen in Brazil where transgenic mosquitoes were released from June 2013 to September 2015. Contrary to claims made, genes…
The NBRC-led team of researchers has identified the molecular and cellular mechanisms by which Zika virus causes microcephaly. The envelop protein of the virus was responsible for arresting the proliferation of human…
Of the two small molecules tested, IIT Roorkee researchers have found one of them has good antiviral activity against chikungunya virus. The small molecule was able to achieve almost 99% reduction…
The Piperazine drug used for treating worm infections and HIV has been able to inhibit the replication of chikungunya virus by nearly 98%. A drug to treat chikungunya virus infection is in…
The Hyderabad-based Bharat Biotech has begun a Phase I human clinical trial of the indigenously developed chikungunya vaccine three months ago. The vaccine uses a killed virus. The Phase I…
With conventional vector controlling measures against dengue- and Zika-causing Aedes aegypti mosquitoes failing, several countries have started caged and even open field trials using genetically modified mosquitoes. India has signed…
Zika is an arbovirus infection which occurs through the bite of several different species of Aedes mosquitoes, including the Aedes aegypti which is active during the day; it can also…
It may well be said that the surveillance system put in place by the Health Ministry achieved a measure of success in identifying three adults who were infected with the Zika virus between…
